Testosterone undecanoate mechanism of action: androgen receptors and protein synthesis
Testosterone undecanoate is the longest-acting injectable form of testosterone in routine medical use, allowing dosing every few months. Its mechanism of action is simply that of testosterone itself, but the undecanoate ester changes how the hormone is delivered. This editorial overview explains the chemistry, the receptor biology, and the effect on protein synthesis.
What testosterone undecanoate is
Testosterone undecanoate is an ester of testosterone — the natural male sex hormone — joined to undecanoic acid, a long fatty-acid chain of eleven carbons. It exists in two main forms: an oral capsule, absorbed partly through the lymphatic system, and a long-acting intramuscular injection used for testosterone replacement therapy.
The injectable form is notable for its very long duration of action, allowing injections only every ten to fourteen weeks once a steady state is reached. This makes it convenient for men on long-term testosterone replacement, reducing the frequency of injections compared with shorter esters such as enantate or cypionate.
In the UK, testosterone undecanoate is a prescription-only and controlled substance, used principally to treat male hypogonadism — a confirmed deficiency of the body's own testosterone. Its medical use is guided by diagnosis, blood tests and monitoring, and it is not a product for casual use.
Because the active molecule, once the ester is removed, is testosterone itself, its mechanism of action is the mechanism of testosterone. The undecanoate ester is essentially a delivery system, as the next section explains.
The role of the undecanoate ester
Testosterone in its pure form is cleared from the body very quickly, which is why it is impractical as a long-acting injection on its own. Attaching a fatty-acid ester makes the molecule more fat-soluble, so that when injected into muscle it forms a depot from which the hormone is released slowly. The longer the fatty-acid chain, the slower the release.
Undecanoate, with its eleven-carbon chain, is one of the longest esters in clinical use, which is precisely why it produces such a prolonged effect. After injection, enzymes called esterases gradually cleave the ester bond, releasing free testosterone into the circulation over weeks. The ester itself is pharmacologically inert; it only governs the timing of release.
This slow release has a clinical advantage: it avoids the sharp peaks and troughs seen with shorter esters, producing more stable testosterone levels. Stable levels mean fewer of the mood and energy fluctuations that some men experience with frequent, shorter-acting injections.
The ester, then, does not change what testosterone does — it changes how long and how smoothly the hormone is delivered. Understanding this separates the delivery mechanism (the ester) from the biological mechanism (testosterone acting on receptors), which is the subject of the next section.
Binding the androgen receptor
Once free testosterone is in the circulation, it acts just as the body's own testosterone does. It enters cells and binds to the androgen receptor, a protein found inside target cells. The binding of testosterone changes the receptor's shape and activates it, allowing the hormone-receptor complex to move into the cell nucleus.
In the nucleus, the activated receptor binds to specific regions of DNA and regulates the transcription of target genes — effectively turning certain genes on or off. This is the fundamental mechanism by which testosterone exerts its wide-ranging effects on muscle, bone, the reproductive system, blood production and the brain.
In some tissues, testosterone is first converted to more potent or different molecules. The enzyme 5-alpha-reductase converts it to dihydrotestosterone, which binds the androgen receptor more strongly and mediates effects in the skin, hair follicles and prostate. The enzyme aromatase converts a portion to oestradiol, which has its own important roles in bone health, lipids and libido in men.
This receptor-mediated, gene-regulating mechanism is shared by all androgens. What distinguishes testosterone undecanoate is not its mechanism but its pharmacokinetics — the long, smooth delivery provided by the ester. The biology at the receptor is simply that of testosterone.
Effects on protein synthesis and tissues
One of the most studied consequences of androgen-receptor activation in muscle is an increase in muscle protein synthesis. By regulating genes involved in building contractile proteins and by activating satellite cells that support muscle-fibre growth, testosterone promotes an increase in muscle mass and strength. This is the basis of its anabolic effect.
The classic work of Bhasin and colleagues demonstrated that testosterone increases lean body mass and muscle size in a dose-dependent manner, with the effect amplified when combined with resistance training. Importantly, those effects on muscle were seen at supraphysiological doses in research settings, and the anabolic benefit in replacement therapy is about restoring normal function in deficient men, not building beyond normal.
| Tissue / system | Effect of androgen-receptor activation |
|---|---|
| Skeletal muscle | Increased protein synthesis, mass and strength |
| Bone | Supports bone mineral density |
| Bone marrow | Stimulates red-blood-cell production |
| Reproductive | Maintains libido and sexual function |
| Brain / mood | Influences mood and energy |
Beyond muscle, androgen-receptor activation supports bone mineral density, stimulates the production of red blood cells, maintains libido and sexual function, and influences mood and energy. In men with genuine testosterone deficiency, restoring these functions is the goal of replacement therapy.
It is worth stressing that these are the effects of testosterone at physiological levels. At the much higher levels associated with non-medical use, the same mechanisms are pushed beyond normal, which is where many of the health risks of anabolic steroid misuse arise — a different topic from the mechanism itself.
Medical use and monitoring
Testosterone undecanoate's medical use is in testosterone replacement therapy for men with confirmed hypogonadism. The diagnosis requires both characteristic symptoms and consistently low testosterone on morning blood tests, interpreted by a clinician. The Endocrine Society guidance does not recommend testosterone for men without a confirmed deficiency.
Because the injectable form is long-acting, dosing is infrequent once a steady state is reached, which is convenient but means that any adverse effect takes longer to wear off. For this reason, the first injections are spaced to assess tolerance, and monitoring is ongoing. The aim of therapy is to restore testosterone to the mid-normal range, not to exceed it.
Monitoring during therapy typically includes testosterone levels, the haematocrit (because testosterone stimulates red-cell production and can thicken the blood), prostate-specific antigen in older men, and a review of symptoms and cardiovascular risk. These checks catch the recognised risks of therapy early.
The injectable undecanoate carries a specific, if rare, caution: pulmonary oil microembolism and anaphylaxis have been reported immediately after injection, which is why it is administered slowly and under observation in a clinical setting. This is one reason the drug is given by a healthcare professional rather than self-administered casually.
Conclusions of the editorial team
Testosterone undecanoate works through the mechanism of testosterone itself: free testosterone binds the androgen receptor, which regulates genes to increase muscle protein synthesis and support bone, blood, libido and mood. The undecanoate ester is a delivery system, not a different drug — its long chain produces slow, smooth, long-lasting release.
That smooth delivery is the drug's distinctive clinical advantage, giving stable levels with infrequent dosing. Its medical use is to restore normal function in men with confirmed deficiency, under diagnosis and monitoring, which is a very different context from non-medical high-dose use.
Readers may also find our material on how testosterone esters differ, on the androgen receptor in muscle, and on monitoring during testosterone replacement useful alongside this overview.
References
- Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1–7.
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.
- Nieschlag E, Behre HM, Nieschlag S (eds). Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012.
- Edelstein D, Basaria S. Testosterone undecanoate in the treatment of male hypogonadism. Expert Opin Pharmacother. 2010;11(12):2095–2106.
- Electronic Medicines Compendium. Nebido 1000 mg/4 mL solution for injection: Summary of Product Characteristics. Datapharm; 2023.
- Handelsman DJ. Androgen physiology, pharmacology and abuse. In: Endotext. MDText.com; 2020.
